Repurposing heart drugs to target cancer cells

by MRC London Institute of Medical SciencesCredit: CC0 Public DomainSenescence is a cellular stress response that results in the stable growth arrest of old and damaged cells. The past decade has reve

Updated on: April 07,2024

Repurposing heart drugs to target cancer cells

by MRC London Institute of Medical SciencesCredit: CC0 Public DomainSenescence is a cellular stress response that results in the stable growth arrest of old and damaged cells. The past decade has reve

Updated on:April 07,2024

Shortages of essential medicines for pediatric cancer patients threaten outcomes

by Baylor College of MedicineCredit: CC0 Public DomainShortages of essential chemotherapy drugs for children undergoing cancer treatment has been an increasingly frequent obstacle for patients an

Updated on: March 06,2024

Shortages of essential medicines for pediatric cancer patients threaten outcomes

by Baylor College of MedicineCredit: CC0 Public DomainShortages of essential chemotherapy drugs for children undergoing cancer treatment has been an increasingly frequent obstacle for patients an

Updated on:March 06,2024

New marker could detect fatal breast cancer up to one year earlier than current methods

by BioMed CentralMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA new marker that could be used to diagnose fatal breast cancer up to one year ah

Updated on: March 01,2024

New marker could detect fatal breast cancer up to one year earlier than current methods

by BioMed CentralMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA new marker that could be used to diagnose fatal breast cancer up to one year ah

Updated on:March 01,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on: January 02,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on:January 02,2024

Loss of cilia leads to melanoma

by University of ZurichPigment cells (blue/green) with cilium (light green with red base). Credit: Daniel Zingg, Netherlands Cancer InstituteMost cells in the human body have a cilium, a slender

Updated on: March 06,2024

Loss of cilia leads to melanoma

by University of ZurichPigment cells (blue/green) with cilium (light green with red base). Credit: Daniel Zingg, Netherlands Cancer InstituteMost cells in the human body have a cilium, a slender

Updated on:March 06,2024

Exercise can now be prescribed like medicine for people with and beyond cancer

by Katie Bohn,Pennsylvania State UniversityCredit: CC0 Public DomainIt's well known that exercise is good for preventing and treating many forms of heart disease, but less commonly known are

Updated on: March 06,2024

Exercise can now be prescribed like medicine for people with and beyond cancer

by Katie Bohn,Pennsylvania State UniversityCredit: CC0 Public DomainIt's well known that exercise is good for preventing and treating many forms of heart disease, but less commonly known are

Updated on:March 06,2024

COVID-19 pandemic could have led to 20,000 prostate cancer diagnosis being missed

byUniversity of SurreyObserved and predicted trends over time from January 2015 to July 2023 showing rates per 100 000 registered adult men (A) prostate cancer incidence, (B) prevalence, and (C)

Updated on: March 30,2024

COVID-19 pandemic could have led to 20,000 prostate cancer diagnosis being missed

byUniversity of SurreyObserved and predicted trends over time from January 2015 to July 2023 showing rates per 100 000 registered adult men (A) prostate cancer incidence, (B) prevalence, and (C)

Updated on:March 30,2024

Breast cancer patients with higher BMI more likely to experience heart damage during chemotherapy, study finds

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainBreast cancer survival rates have improved considerably in the last few decades in Colombia, but factors that increase the likel

Updated on: January 23,2024

Breast cancer patients with higher BMI more likely to experience heart damage during chemotherapy, study finds

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainBreast cancer survival rates have improved considerably in the last few decades in Colombia, but factors that increase the likel

Updated on:January 23,2024

A two-for-one approach to boost melanoma immunotherapy

by Sanford Burnham Prebys Medical Discovery InstituteCredit: Unsplash/CC0 Public DomainNew research from Sanford Burnham Prebys has helped explain how melanoma evades the immune system and may gu

Updated on: February 03,2024

A two-for-one approach to boost melanoma immunotherapy

by Sanford Burnham Prebys Medical Discovery InstituteCredit: Unsplash/CC0 Public DomainNew research from Sanford Burnham Prebys has helped explain how melanoma evades the immune system and may gu

Updated on:February 03,2024

New reports examine COVID's radiotherapy interruption implications

by University of Tennessee Health Science Center(A-D) Major radiation therapy (RT) interruption rates before and during the pandemic mapped by ZIP code across the metropolitan region by race and insur

Updated on: January 11,2024

New reports examine COVID's radiotherapy interruption implications

by University of Tennessee Health Science Center(A-D) Major radiation therapy (RT) interruption rates before and during the pandemic mapped by ZIP code across the metropolitan region by race and insur

Updated on:January 11,2024

Breast cancer test could guide treatment for more aggressive subtype

byInstitute of Cancer ResearchKi67 changes from baseline to surgery stratified by intrinsic subtype at baseline within a. Treated and b. Controls. Abbreviations: HER2-E, HER2-Enriched Subtype; L

Updated on: January 02,2024

Breast cancer test could guide treatment for more aggressive subtype

byInstitute of Cancer ResearchKi67 changes from baseline to surgery stratified by intrinsic subtype at baseline within a. Treated and b. Controls. Abbreviations: HER2-E, HER2-Enriched Subtype; L

Updated on:January 02,2024

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on: January 11,2024

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on:January 11,2024